Cargando…

Methylation-dependent MCM6 repression induced by LINC00472 inhibits triple-negative breast cancer metastasis by disturbing the MEK/ERK signaling pathway

Long noncoding RNAs (lncRNAs) have been identified to be dysregulated in multiple cancer types, which are speculated to be of vital significance in regulating several hallmarks of cancer biology. Triple-negative breast cancer (TNBC) is acknowledged as an aggressive subtype of breast cancer. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Guoli, Fan, Xulong, Zhang, Pusheng, Liu, Xuewen, Huang, Lei, Ji, Shufeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950301/ https://www.ncbi.nlm.nih.gov/pubmed/33668040 http://dx.doi.org/10.18632/aging.103568

Ejemplares similares

Matrine Restrains Cell Growth and Metastasis by Up-Regulating LINC00472 in Bladder Carcinoma
por: Li, Linlin, et al.
Publicado: (2020)

Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer
por: Shen, Yi, et al.
Publicado: (2015)

Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma
por: Gao, Shuoze, et al.
Publicado: (2021)

lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR-195/497 cluster
por: Shao, Guoli, et al.
Publicado: (2019)

Retracted: Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence
por: Liu, Mingyu, et al.
Publicado: (2018)

LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1
por: Deng, Xiangying, et al.
Publicado: (2020)

Down-regulation of LINC00472 promotes osteosarcoma tumorigenesis by reducing FOXO1 expressions via miR-300
por: Zhang, Jingwei, et al.
Publicado: (2020)

Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
por: Zhang, Ying, et al.
Publicado: (2022)

LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis
por: Liu, Xiu, et al.
Publicado: (2022)

Linc00472 suppresses proliferation and promotes apoptosis through elevating PDCD4 expression by sponging miR-196a in colorectal cancer
por: Ye, Yafei, et al.
Publicado: (2018)

Long non-coding RNA LINC00472 inhibits oral squamous cell carcinoma via miR-4311/GNG7 axis
por: Zou, Chen, et al.
Publicado: (2022)

Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer
por: Ji, Shufeng, et al.
Publicado: (2023)

Retraction: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4
por: Fisher, Laura
Publicado: (2021)

Long Noncoding RNA 00472: A Novel Biomarker in Human Diseases
por: Ren, Dan-yang, et al.
Publicado: (2021)

Long Noncoding RNA LINC00472 Inhibits Proliferation and Promotes Apoptosis of Lung Adenocarcinoma Cells via Regulating miR-24-3p/DEDD
por: Su, Chongyu, et al.
Publicado: (2018)

LINC00472 suppressed by ZEB1 regulates the miR‐23a‐3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer
por: Bi, Cong, et al.
Publicado: (2021)

Retracted Article: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4
por: Lu, Pengwei, et al.
Publicado: (2018)

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway
por: Song, Ye, et al.
Publicado: (2021)

DNAzyme-based probe for circulating microRNA detection in peripheral blood
por: Shao, Guoli, et al.
Publicado: (2015)

LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270
por: Zou, Aimei, et al.
Publicado: (2019)

LINC00472 inhibits cell migration by enhancing intercellular adhesion and regulates H3K27ac level via interacting with P300 in renal clear cell carcinoma
por: Wang, Songmao, et al.
Publicado: (2022)

Tanshinone IIA induces autophagy in colon cancer cells through MEK/ERK/mTOR pathway
por: Qian, Jun, et al.
Publicado: (2020)

MEK/ERK addiction in CNL/aCML
por: Kesarwani, Meenu, et al.
Publicado: (2017)

LINC00312 represses proliferation and metastasis of colorectal cancer cells by regulation of miR‐21
por: Li, Gang, et al.
Publicado: (2018)

Retraction Notice to: LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270
por: Zou, Aimei, et al.
Publicado: (2022)

The LINC Complex Inhibits Excessive Chromatin Repression
por: Amiad Pavlov, Daria, et al.
Publicado: (2023)

Lipocalin-2 Inhibits Osteosarcoma Cell Metastasis by Suppressing MET Expression via the MEK–ERK Pathway
por: Lu, Ko-Hsiu, et al.
Publicado: (2021)

SIPA1 Regulates LINC01615 to Promote Metastasis in Triple-Negative Breast Cancer
por: Xiang, Yuan, et al.
Publicado: (2022)

Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
por: Wu, Pui-Kei, et al.
Publicado: (2020)

The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
por: Thomas, Kubin, et al.
Publicado: (2020)

The MEK5/ERK5 Pathway in Health and Disease
por: Paudel, Rupesh, et al.
Publicado: (2021)

CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
por: Du, Jinpeng, et al.
Publicado: (2022)

Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
por: Gagliardi, Maria, et al.
Publicado: (2020)

Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis
por: Shao, Guo-Li, et al.
Publicado: (2018)

ERK1b, a 46‐kDa ERK isoform that is differentially regulated by MEK
por: Yung, Yuval, et al.
Publicado: (2022)

MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK–ERK Signaling
por: Evans, Catherine, et al.
Publicado: (2013)

Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer
por: Nokin, Marie-Julie, et al.
Publicado: (2019)

Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9
por: Hsieh, Min-Hong, et al.
Publicado: (2019)

Correction: CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
por: Du, Jinpeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sr1kbbrgmn95m8j14krdgs7rm2